Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01384669 |
Recruitment Status :
Completed
First Posted : June 29, 2011
Last Update Posted : March 28, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Papillary Thyroid Microcarcinoma |
Study Type : | Observational |
Actual Enrollment : | 29 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis |
Study Start Date : | May 2011 |
Actual Primary Completion Date : | May 26, 2013 |
Actual Study Completion Date : | May 26, 2013 |

Group/Cohort |
---|
Group 1
papillary thyroid microcarcinoma without lymph node metastasis
|
Group 2
papillary thyroid microcarcinoma with lateral lymph node metastasis
|
- mRNA expression pattern by microarray analysis [ Time Frame: 24-hour after surgical removement ]mRNA expression differences between papillary thyroid microcarcinoma without lateral neck node metastasis and the one with lateral neck node metastasis. (The outcome will be measured within 24-hour after surgical removement using papillary thyroid microcarcinoma tissue.)
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- age≥20 years old
- Conventional type papillary thyroid microcarcinoma (0.5cm≤tumor size≤1.0cm)
- group 1: no lymph node metastasis /group 2: with lateral neck node metastasis
Exclusion Criteria:
- tumor with capsular invasion (T3 tumor)
- distant metastasis
- combined underlying thyroiditis

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01384669
Korea, Republic of | |
Severance Hospital | |
Seoul, Korea, Republic of, 120-752 |
Responsible Party: | Yonsei University |
ClinicalTrials.gov Identifier: | NCT01384669 |
Other Study ID Numbers: |
4-2011-0212 |
First Posted: | June 29, 2011 Key Record Dates |
Last Update Posted: | March 28, 2019 |
Last Verified: | December 2013 |
Thyroid Diseases Endocrine System Diseases |